HCA
Harbor Capital Advisors Portfolio holdings
AUM
$2.38B
This Quarter Return
+1.8%
1 Year Return
+20%
3 Year Return
+97.89%
5 Year Return
–
10 Year Return
–
AUM
$275M
AUM Growth
–
Cap. Flow
+$275M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
92
New
92
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Microsoft
MSFT
|
$13.4M |
| 2 |
Lam Research
LRCX
|
$10.7M |
| 3 |
Tesla
TSLA
|
$10.6M |
| 4 |
NVIDIA
NVDA
|
$9.22M |
| 5 |
Amazon
AMZN
|
$8.98M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 48.21% |
| 2 | Consumer Discretionary | 18.52% |
| 3 | Healthcare | 17.22% |
| 4 | Communication Services | 9.83% |
| 5 | Financials | 2.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arrowhead Research
ARWR
$3.05B
| $1.68M | 0.61% |
+25,358
| New | +$1.68M |
|
52
Arvinas
ARVN
$568M
| $1.61M | 0.59% |
+19,633
| New | +$1.61M |
|
|
CTLT
53
DELISTED
CATALENT, INC.
CTLT
| $1.6M | 0.58% |
+12,522
| New | +$1.6M |
|
54
Insulet
PODD
$23.9B
| $1.57M | 0.57% |
+5,905
| New | +$1.57M |
|
|
ZEN
55
DELISTED
ZENDESK INC
ZEN
| $1.56M | 0.57% |
+14,943
| New | +$1.56M |
|
|
BPMC
56
DELISTED
Blueprint Medicines
BPMC
| $1.53M | 0.56% |
+14,314
| New | +$1.53M |
|
57
Ironwood Pharmaceuticals
IRWD
$214M
| $1.42M | 0.52% |
+121,318
| New | +$1.42M |
|
|
AMED
58
DELISTED
Amedisys
AMED
| $1.38M | 0.5% |
+8,532
| New | +$1.38M |
|
59
DexCom
DXCM
$29.5B
| $1.36M | 0.49% |
+2,524
| New | +$1.36M |
|
60
Avidity Biosciences
RNA
$5.99B
| $1.35M | 0.49% |
+56,648
| New | +$1.35M |
|
|
SIVB
61
DELISTED
SVB Financial Group
SIVB
| $1.32M | 0.48% |
+1,949
| New | +$1.32M |
|
62
Krystal Biotech
KRYS
$4.27B
| $1.29M | 0.47% |
+18,472
| New | +$1.29M |
|
63
Regenxbio
RGNX
$451M
| $1.25M | 0.46% |
+38,253
| New | +$1.25M |
|
|
GTM
64
ZoomInfo Technologies
GTM
$3.47B
| $1.25M | 0.45% |
+19,399
| New | +$1.25M |
|
65
Cooper Companies
COO
$13.4B
| $1.2M | 0.44% |
+2,869
| New | +$1.2M |
|
66
Idexx Laboratories
IDXX
$51.8B
| $1.16M | 0.42% |
+1,758
| New | +$1.16M |
|
67
Bio-Rad Laboratories Class A
BIO
$8.06B
| $1.14M | 0.42% |
+1,510
| New | +$1.14M |
|
|
AUTL
68
Autolus Therapeutics
AUTL
$399M
| $1.1M | 0.4% |
+211,319
| New | +$1.1M |
|
69
Kymera Therapeutics
KYMR
$2.95B
| $1.07M | 0.39% |
+16,851
| New | +$1.07M |
|
70
Masimo
MASI
$7.59B
| $1.07M | 0.39% |
+3,652
| New | +$1.07M |
|
71
Synlogic
SYBX
$17M
| $1.06M | 0.39% |
+437,550
| New | +$1.06M |
|
72
Lightspeed Commerce
LSPD
$1.67B
| $1.03M | 0.37% |
+25,439
| New | +$1.03M |
|
73
Zscaler
ZS
$43.1B
| $1.02M | 0.37% |
+3,158
| New | +$1.02M |
|
74
Replimune Group
REPL
$422M
| $1.01M | 0.37% |
+37,105
| New | +$1.01M |
|
75
Iovance Biotherapeutics
IOVA
$807M
| $984K | 0.36% |
+51,540
| New | +$984K |
|